You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 6, June 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Viral Infections
 •Neuropathology
 •Alert me on articles by topic

Stiff-Person Syndrome Following West Nile Fever

Sharon Hassin-Baer, MD; Eilon D. Kirson, MD, PhD; Lester Shulman, PhD; Aron S. Buchman, MD; Hanna Bin, PhD; Musa Hindiyeh, PhD; Lea Markevich; Ella Mendelson, PhD

Arch Neurol. 2004;61:938-941.

Background  Stiff-person syndrome is a rare autoimmune disorder associated with antibodies against glutamic acid decarboxylase (GAD), the key enzyme in {gamma}-aminobutyric acid synthesis. In most cases, a trigger cannot be identified.

Objective  To describe a 41-year-old man who developed stiff-person syndrome and antibodies to GAD following acute West Nile virus infection.

Design  A case report and a search in GenBank for common epitopes.

Result  The search revealed a stretch of 12 amino acids in the NS1 protein of West Nile virus with a high degree of homology to the GAD65 region (an isoform of GAD) containing the PEVKEK motif.

Conclusion  Cross-reactivity between antibodies directed against West Nile virus and GAD may have contributed to the development of stiff-person syndrome in this patient.


From the Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, Israel (affiliated with the Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel) (Drs Hassin-Baer, Kirson, and Buchman); the Central Virology Laboratory, Public Health Laboratories, Ministry of Health, Tel-Hashomer (Drs Shulman, Bin, Hindiyeh, and Mendelson); the Institute of Endocrinology, Tel-Aviv Sourasky Medical Center, Tel-Aviv (Ms Markevich); the Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel (Dr Mendelson); and the Department of Neurological Sciences, Rush Medical College, Chicago, Ill (Dr Buchman).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.